United Therapeutics Corporation (UTHR) Insider Trading

Total insider buys:
  • $999,400.80
Total insider sells:
  • $776,550,129.77
Most recent insider trade:
  • Nov. 21, 2024
Most active insider trader:
  • Martine A Rothblatt
Trader NameDateTitleAmountPriceTypeTotal Value
Oct. 13, 2014CEO2,592$124.31Sell$322,211.52
Oct. 9, 2014CEO9,662$129.97Sell$1,255,770.14
Oct. 9, 2014EVP5,000$130.59Sell$652,950.00
Oct. 8, 2014CEO2,211$131.50Sell$290,746.50
Oct. 7, 2014COO35,000$130.14Sell$4,554,900.00
Oct. 6, 2014CEO2,592$129.32Sell$335,197.44
Oct. 3, 2014COO10,000$129.79Sell$1,297,900.00
Oct. 2, 2014EVP6,000$129.46Sell$776,760.00
Oct. 2, 2014CFO10,000$129.46Sell$1,294,600.00
Oct. 2, 2014CEO9,662$127.72Sell$1,234,030.64
Oct. 2, 2014Director1,500$130.65Sell$195,975.00
Oct. 1, 2014CEO2,211$127.40Sell$281,681.40
Sept. 30, 2014COO20,000$128.65Sell$2,573,000.00
Sept. 25, 2014CEO5,547$134.26Sell$744,740.22
Sept. 25, 2014Director20,000$134.94Sell$2,698,800.00
Sept. 25, 2014EVP5,000$133.77Sell$668,850.00
Sept. 23, 2014COO50,000$131.02Sell$6,551,000.00
Sept. 19, 2014COO10,000$129.60Sell$1,296,000.00
Sept. 18, 2014CFO10,000$130.93Sell$1,309,300.00
Sept. 18, 2014EVP6,000$130.93Sell$785,580.00
Sept. 18, 2014CEO9,662$127.35Sell$1,230,455.70
Sept. 17, 2014COO20,000$127.01Sell$2,540,200.00
Sept. 15, 2014CEO50,000$124.52Sell$6,226,000.00
Sept. 11, 2014EVP5,000$120.70Sell$603,500.00
Sept. 11, 2014CEO9,662$120.79Sell$1,167,072.98
Sept. 10, 2014CEO50,000$120.01Sell$6,000,500.00
Sept. 10, 2014Director20,000$119.95Sell$2,399,000.00
Sept. 5, 2014COO10,000$111.29Sell$1,112,900.00
Sept. 4, 2014Director3,000$113.40Sell$340,200.00
Sept. 4, 2014CFO10,000$112.38Sell$1,123,800.00
Sept. 4, 2014CEO9,662$112.87Sell$1,090,549.94
Sept. 4, 2014EVP6,000$112.38Sell$674,280.00
Aug. 28, 2014EVP5,000$92.07Sell$460,350.00
Aug. 28, 2014CEO7,014$92.46Sell$648,514.44
Aug. 21, 2014CEO9,640$93.13Sell$897,773.20
Aug. 21, 2014CFO10,000$93.75Sell$937,500.00
Aug. 15, 2014Director1,500$91.14Sell$136,710.00
Aug. 14, 2014EVP10,000$88.41Sell$884,100.00
Aug. 14, 2014CEO4,115$88.39Sell$363,724.85
Aug. 7, 2014CEO4,115$88.40Sell$363,766.00
Aug. 7, 2014Director5,000$88.23Sell$441,150.00
Aug. 7, 2014CFO10,000$86.44Sell$864,400.00
Aug. 1, 2014Director3,000$89.52Sell$268,560.00
Aug. 1, 2014COO10,000$89.88Sell$898,800.00
July 31, 2014CEO3,933$90.95Sell$357,706.35
July 29, 2014COO50,000$96.25Sell$4,812,500.00
July 25, 2014COO10,000$91.54Sell$915,400.00
July 24, 2014CEO9,228$93.15Sell$859,588.20
July 17, 2014CFO10,000$89.74Sell$897,400.00
July 17, 2014CEO3,833$90.87Sell$348,304.71
  • Insiders are both buying and selling United Therapeutics Corporation stock.

  • The insider traders at United Therapeutics Corporation are: Martine A Rothblatt, Paul A Mahon, Roger Jeffs, Martine A. Rothblatt, Martine Rothblatt, Christopher Causey, John Maxim Ferrari, Raymond Dwek, Christopher Patusky, Paul Mahon, David Zaccardelli, Richard Giltner, James Edgemond, Nilda Mesa, Louis W Sullivan, Tommy G Thompson, Judy D Olian, Michael Benkowitz, Ray Kurzweil, Paul A. Mahon, Louis Sullivan, R Paul Gray, Judy D. Olian, Tommy G. Thompson, DWEK RAYMOND, and MAHON PAUL A

  • The most active insider trader at United Therapeutics Corporation is Martine A Rothblatt with 386 trades.

  • Martine A Rothblatt has sold the most United Therapeutics Corporation stock with a total value of $372,318,923.20.

  • Martine A Rothblatt has bought the most United Therapeutics Corporation stock with a total value of $1,217,751.60.

  • The most recent insider trade for United Therapeutics Corporation was on Nov. 21, 2024.

  • The single biggest insider buy for United Therapeutics Corporation was from Martine A Rothblatt with a total value of $466,650.00 on Dec. 21, 2012.

  • The single biggest insider sell for United Therapeutics Corporation was from Michael Benkowitz with a total value of $8,084,500.00 on Aug. 7, 2024.